SYSTEMATIC REVIEW: ANAPLASTIC LARGE CELL LYMPHOMA FOLLOWING BREAST IMPLANT SURGERY

Highlights: • BIA-ALCL, a T-cell lymphoma associated with breast implants, is posing a growing medical challenge due to the increasing use of implants for cosmetic and reconstructive purposes • The majority of BIA-ALCL cases were associated with cosmetic reasons for breast implants, and textured...

Full description

Saved in:
Bibliographic Details
Main Authors: Kezia Eveline, Rizqi Shabrina Lestari, Beta Subakti Nata’admadja, Lavonia Berlina Adzalika
Format: Article
Language:English
Published: UNIVERSITAS AIRLANGGA 2023-06-01
Series:Jurnal Rekonstruksi dan Estetik
Subjects:
Online Access:https://e-journal.unair.ac.id/JRE/article/view/31215
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841556942240088064
author Kezia Eveline
Rizqi Shabrina Lestari
Beta Subakti Nata’admadja
Lavonia Berlina Adzalika
author_facet Kezia Eveline
Rizqi Shabrina Lestari
Beta Subakti Nata’admadja
Lavonia Berlina Adzalika
author_sort Kezia Eveline
collection DOAJ
description Highlights: • BIA-ALCL, a T-cell lymphoma associated with breast implants, is posing a growing medical challenge due to the increasing use of implants for cosmetic and reconstructive purposes • The majority of BIA-ALCL cases were associated with cosmetic reasons for breast implants, and textured implants were predominantly implicated. Abstract: Introduction: BIA-ALCL, a T-cell lymphoma associated with breast implants, poses a growing medical challenge despite its relatively low occurrence, due to the increasing use of implants for cosmetic and reconstructive purposes. Our objective is to review the incidence, characteristics of patients, implant types, management, and outcome of BIA-ALCL. Methods: Pubmed and Science Direct databases were searched to identify case series and observational research. A systematic review was conducted by looking up the keywords "breast implant” and "anaplastic large cell lymphoma”. Result: 11 relevant articles were assessed. A total of 353 BIA-ALCL cases have been reported. The mean age at diagnosis was 59.6 years. More than half (53.26%) of the reasons for the breast implants in BIA-ALCL patients were cosmetic. The mean time from breast implant placement to diagnosis was 9.99 years. The majority (71.39%) of documented BIA-ALCL cases have been associated with textured devices. BIA-ALCL patients mainly presented with seroma (54.67%). Outcomes included remission (71%), death because of the disease (4.25%), and recurrence (3.96%) with a mean time of duration of follow-up was 2.53 years. Conclusion: BIA-ALCL is rare cancer in some patients with breast implants but is increasing in incidence largely due to consistent and long-term follow-up. It is important for physicians involved in the care of patients with breast implants to be aware of BIA-ALCL and do routine breast exams.
format Article
id doaj-art-6262ceeb40394c1b9b1dac3ed247ca31
institution Kabale University
issn 2301-7937
2774-6062
language English
publishDate 2023-06-01
publisher UNIVERSITAS AIRLANGGA
record_format Article
series Jurnal Rekonstruksi dan Estetik
spelling doaj-art-6262ceeb40394c1b9b1dac3ed247ca312025-01-07T04:32:20ZengUNIVERSITAS AIRLANGGAJurnal Rekonstruksi dan Estetik2301-79372774-60622023-06-0181475810.20473/jre.v8i1.3121525552SYSTEMATIC REVIEW: ANAPLASTIC LARGE CELL LYMPHOMA FOLLOWING BREAST IMPLANT SURGERYKezia Eveline0https://orcid.org/0000-0001-9513-5650Rizqi Shabrina Lestari1Beta Subakti Nata’admadja2https://orcid.org/0000-0001-7351-9768Lavonia Berlina Adzalika3https://orcid.org/0000-0001-8525-0284Department of Plastic Surgery, Reconstructive, and Aesthetic, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia Department of Plastic Surgery, Reconstructive, and Aesthetic, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia Department of Plastic Surgery, Reconstructive, and Aesthetic, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Academic Hospital, Surabaya, IndonesiaDepartment of Plastic Surgery, Reconstructive, and Aesthetic, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia Highlights: • BIA-ALCL, a T-cell lymphoma associated with breast implants, is posing a growing medical challenge due to the increasing use of implants for cosmetic and reconstructive purposes • The majority of BIA-ALCL cases were associated with cosmetic reasons for breast implants, and textured implants were predominantly implicated. Abstract: Introduction: BIA-ALCL, a T-cell lymphoma associated with breast implants, poses a growing medical challenge despite its relatively low occurrence, due to the increasing use of implants for cosmetic and reconstructive purposes. Our objective is to review the incidence, characteristics of patients, implant types, management, and outcome of BIA-ALCL. Methods: Pubmed and Science Direct databases were searched to identify case series and observational research. A systematic review was conducted by looking up the keywords "breast implant” and "anaplastic large cell lymphoma”. Result: 11 relevant articles were assessed. A total of 353 BIA-ALCL cases have been reported. The mean age at diagnosis was 59.6 years. More than half (53.26%) of the reasons for the breast implants in BIA-ALCL patients were cosmetic. The mean time from breast implant placement to diagnosis was 9.99 years. The majority (71.39%) of documented BIA-ALCL cases have been associated with textured devices. BIA-ALCL patients mainly presented with seroma (54.67%). Outcomes included remission (71%), death because of the disease (4.25%), and recurrence (3.96%) with a mean time of duration of follow-up was 2.53 years. Conclusion: BIA-ALCL is rare cancer in some patients with breast implants but is increasing in incidence largely due to consistent and long-term follow-up. It is important for physicians involved in the care of patients with breast implants to be aware of BIA-ALCL and do routine breast exams.https://e-journal.unair.ac.id/JRE/article/view/31215anaplastic large cell lymphoma bia-alcl breast implant health risk
spellingShingle Kezia Eveline
Rizqi Shabrina Lestari
Beta Subakti Nata’admadja
Lavonia Berlina Adzalika
SYSTEMATIC REVIEW: ANAPLASTIC LARGE CELL LYMPHOMA FOLLOWING BREAST IMPLANT SURGERY
Jurnal Rekonstruksi dan Estetik
anaplastic large cell lymphoma
bia-alcl
breast implant
health risk
title SYSTEMATIC REVIEW: ANAPLASTIC LARGE CELL LYMPHOMA FOLLOWING BREAST IMPLANT SURGERY
title_full SYSTEMATIC REVIEW: ANAPLASTIC LARGE CELL LYMPHOMA FOLLOWING BREAST IMPLANT SURGERY
title_fullStr SYSTEMATIC REVIEW: ANAPLASTIC LARGE CELL LYMPHOMA FOLLOWING BREAST IMPLANT SURGERY
title_full_unstemmed SYSTEMATIC REVIEW: ANAPLASTIC LARGE CELL LYMPHOMA FOLLOWING BREAST IMPLANT SURGERY
title_short SYSTEMATIC REVIEW: ANAPLASTIC LARGE CELL LYMPHOMA FOLLOWING BREAST IMPLANT SURGERY
title_sort systematic review anaplastic large cell lymphoma following breast implant surgery
topic anaplastic large cell lymphoma
bia-alcl
breast implant
health risk
url https://e-journal.unair.ac.id/JRE/article/view/31215
work_keys_str_mv AT keziaeveline systematicreviewanaplasticlargecelllymphomafollowingbreastimplantsurgery
AT rizqishabrinalestari systematicreviewanaplasticlargecelllymphomafollowingbreastimplantsurgery
AT betasubaktinataadmadja systematicreviewanaplasticlargecelllymphomafollowingbreastimplantsurgery
AT lavoniaberlinaadzalika systematicreviewanaplasticlargecelllymphomafollowingbreastimplantsurgery